The drugs have soared in popularity, with some men taking them for unapproved uses like anti-aging or increasing muscle mass.

Promo materials should also refrain from positioning one approved biosimilar as better than another for the same reference product, per the document, and they shouldn’t suggest that a biosimilar is ...

Amid a swell of regulatory successes in the myasthenia gravis arena this decade, Amgen is wading into the fray with a new ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

BOSTON, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Sesen today announced the launch of TrialS, a next generation regulatory ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

The vast majority of what we do would be eliminated if people fix their diet,” says cardiologist Kim Allan Williams Sr.

With this launch, Ozempic now available in India as a once-weekly injectable formulation of semaglutide. It will be available in a pen format in 0.25 mg, 0.5 mg and 1 mg doses in the country.

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 (approx ₹ 2,200) per week, as it seeks ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 milligram dose at $24.35 per week as it targets a ...

Discover the best fever reducers, recommended by doctors. We reviewed top options like Tylenol, Genexa, and Advil to find safe, effective relief.

Danish drugmaker Novo Nordisk ($NVO) launched its blockbuster diabetes treatment Ozempic (semaglutide injection) in India at ...